{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:37:24Z","timestamp":1792643844140,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,8,8]],"date-time":"2009-08-08T00:00:00Z","timestamp":1249689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00415-009-5279-z","type":"journal-article","created":{"date-parts":[[2009,8,7]],"date-time":"2009-08-07T11:13:24Z","timestamp":1249643604000},"page":"98-102","source":"Crossref","is-referenced-by-count":45,"title":["The relationship between health, disability and quality of life in Myasthenia Gravis: results from an Italian study"],"prefix":"10.1007","volume":"257","author":[{"given":"Matilde","family":"Leonardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Confalonieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Cornelio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,8]]},"reference":[{"key":"5279_CR1","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0895-4356(98)00094-8","volume":"51","author":"G Apolone","year":"1998","unstructured":"Apolone G, Mosconi P (1998) The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 51:1025\u20131036","journal-title":"J Clin Epidemiol"},{"key":"5279_CR2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mus.21053","volume":"38","author":"TM Burns","year":"2008","unstructured":"Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group (2008) Less is more, or almost as much: a 15-item quality of life instrument for myasthenia gravis. Muscle Nerve 38:957\u2013963","journal-title":"Muscle Nerve"},{"key":"5279_CR3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1600-0447.2005.00684.x","volume":"113","author":"MA Buist-Bouwman","year":"2006","unstructured":"Buist-Bouwman MA, De Graaf R, Vollebergh WA, Alonso J, Bruffaerts R, Ormel J (2006) Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries. Acta Psychiatr Scand 113:492\u2013500","journal-title":"Acta Psychiatr Scand"},{"key":"5279_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/108471380500900303","volume":"9","author":"TH Chisolm","year":"2005","unstructured":"Chisolm TH, Abrams HB, McArdle R, Wilson RH, Doyle PJ (2005) The WHO-DAS II: psychometric properties in the measurement of functional health status in adults with acquired hearing loss. Trends Amplif 9:111\u2013126","journal-title":"Trends Amplif"},{"key":"5279_CR5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/j.1440-1614.2004.01448.x","volume":"38","author":"PK Chopra","year":"2004","unstructured":"Chopra PK, Couper JW, Herrman H (2004) The assessment of patients with long-term psychotic disorders: application of the WHO Disability Assessment Schedule II. Aust NZ J Psychiatry 38:753\u2013759","journal-title":"Aust NZ J Psychiatry"},{"key":"5279_CR6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0895-4356(03)00051-9","volume":"54","author":"LA Chwastiak","year":"2003","unstructured":"Chwastiak LA, Von Korff M (2003) Disability in depression and back pain: evaluation of the World Health Organization Disability Assessment Schedule (WHO-DAS II) in a primary care setting. J Clin Epidemiol 54:507\u2013514","journal-title":"J Clin Epidemiol"},{"key":"5279_CR7","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present, and future. J Clin Invest 116:2843\u20132854","journal-title":"J Clin Invest"},{"key":"5279_CR8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0404.1995.tb00471.x","volume":"92","author":"R D\u2019Alessandro","year":"1995","unstructured":"D\u2019Alessandro R, Casmiro M, Benassi G, Rinaldi R, Gamberoni G (1995) Reliable disability scale for myasthenia gravis sensitive to clinical changes. Acta Neurol Scand 92:77\u201382","journal-title":"Acta Neurol Scand"},{"key":"5279_CR9","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/bmj.324.7351.1417","volume":"324","author":"A Garratt","year":"2002","unstructured":"Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R (2002) Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 324:1417","journal-title":"BMJ"},{"key":"5279_CR10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpainsymman.2007.02.041","volume":"35","author":"C Guy-Coichard","year":"2008","unstructured":"Guy-Coichard C, Nguyen DT, Delorme T, Boureau F (2008) Pain in hereditary neuromuscular disorders and myasthenia gravis: a national survey of frequency, characteristics and impact. J Pain Symptom Manage 35:40\u201350","journal-title":"J Pain Symptom Manage"},{"key":"5279_CR11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards: Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323","journal-title":"Neurology"},{"key":"5279_CR12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0404.2005.00378.x","volume":"111","author":"D Lavrnic","year":"2005","unstructured":"Lavrnic D, Vujic A, Rakocevic-Stojanovic V, Stevic Z, Basta I, Pavlovic S, Trikic R, Apostolski S (2005) Cyclosporine in the treatment of myasthenia gravis. Acta Neurol Scand 111:247\u2013252","journal-title":"Acta Neurol Scand"},{"key":"5279_CR13","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(06)69498-1","volume":"368","author":"M Leonardi","year":"2006","unstructured":"Leonardi M, Bickenbach J, Ustun TB, Kostanjsek N, Chatterji S, MHADIE consortium (2006) The definition of disability: what is in a name? Lancet 368:1219\u20131221","journal-title":"Lancet"},{"key":"5279_CR14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00314245","volume":"235","author":"R Mantegazza","year":"1988","unstructured":"Mantegazza R, Antozzi C, Peluchetti D, Sghirlanzoni A, Cornelio F (1988) Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J Neurol 235:449\u2013453","journal-title":"J Neurol"},{"key":"5279_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1254.054","volume":"998","author":"R Mantegazza","year":"2003","unstructured":"Mantegazza R, Baggi F, Antozzi C et al (2003) Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann NY Acad Sci 998:413\u2013423","journal-title":"Ann NY Acad Sci"},{"key":"5279_CR16","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mus.21016","volume":"38","author":"LL Mullins","year":"2008","unstructured":"Mullins LL, Carpentier MY, Paul RH, Sanders DB, the Muscle Study Group (2008) Disease-specific measure of quality of life for Myasthenia Gravis. Muscle Nerve 38:947\u2013956","journal-title":"Muscle Nerve"},{"key":"5279_CR17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s100720100066","volume":"22","author":"L Padua","year":"2001","unstructured":"Padua L, Evoli A, Aprile I, Caliandro P, Mazza S, Padua R, Tonali P (2001) Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurol Sci 22:363\u2013369","journal-title":"Neurol Sci"},{"key":"5279_CR18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/mus.1034","volume":"24","author":"RH Paul","year":"2001","unstructured":"Paul RH, Nash JM, Cohen RA, Gilchristh JM, Goldstein JM (2001) Quality of life and well-being of patients with Myasthenia Gravis. Muscle Nerve 24:512\u2013516","journal-title":"Muscle Nerve"},{"key":"5279_CR19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1468-1331.2006.01149.x","volume":"13","author":"A Rostedt","year":"2006","unstructured":"Rostedt A, Padua L, Stalberg EV (2006) Correlation between regional myasthenic weakness and mental aspects of quality of life. Eur J Neurol 13:191\u2013193","journal-title":"Eur J Neurol"},{"key":"5279_CR20","volume-title":"WHO-DAS II field trials report 1998","author":"TB Ustun","year":"1999","unstructured":"Ustun TB (1999) WHO-DAS II field trials report 1998. WHO, Geneva"},{"key":"5279_CR21","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","volume":"357","author":"A Vincent","year":"2001","unstructured":"Vincent A, Palace J, Hilton-Jones D (2001) Myasthenia Gravis. Lancet 357:2122\u20132128","journal-title":"Lancet"},{"key":"5279_CR22","volume-title":"The International Classification of Functioning, Disability and Health-ICF","author":"World Health Organization","year":"2001","unstructured":"World Health Organization (2001) The International Classification of Functioning, Disability and Health-ICF. WHO, Geneva"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5279-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-009-5279-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-009-5279-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:12:52Z","timestamp":1559070772000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-009-5279-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,8]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["5279"],"URL":"https:\/\/doi.org\/10.1007\/s00415-009-5279-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,8]]}}}